A detailed history of Summit Partners Public Asset Management, LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Summit Partners Public Asset Management, LLC holds 783,069 shares of RXST stock, worth $45.8 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares
783,069
Previous 286,421 173.4%
Holding current value
$45.8 Million
Previous $11.5 Million 249.76%
% of portfolio
1.43%
Previous 0.48%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$35.51 - $57.92 $17.6 Million - $28.8 Million
496,648 Added 173.4%
783,069 $40.4 Million
Q4 2023

Feb 14, 2024

BUY
$20.91 - $40.9 $5.99 Million - $11.7 Million
286,421 New
286,421 $11.5 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.62B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.